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A B S T R A C T
Previous studies have shown that lifestyle modification can successfully prevent or delay development of type 2
diabetes. This trial aimed to test if an underserved, low-income population would engage in a digital diabetes
prevention program and successfully achieve lifestyle changes to reduce their risk of type 2 diabetes.
Participants were recruited from three health care facilities serving low-income populations. The inclusion
criteria were: a recent blood test indicating prediabetes, body mass index (BMI) > 24 kg/m2, age 18–75 years,
not pregnant, not insured, Medicaid insured or Medicaid-eligible, internet or smartphone access, and comfort
reading and writing in English or Spanish. A total of 230 participants were enrolled and started the intervention.
Participants' average age was 48 years, average BMI= 34.8, average initial HbA1c= 5.8, 81% were female, and
45% were Spanish speaking. Eighty percent had Medicaid insurance, 18% were uninsured, and 2% were insured
by a medical safety net plan.
Participants completed a health assessment including measured anthropometrics, HbA1c test, and self-report
questionnaires at baseline, 6 and 12 months. The 52-week digital diabetes prevention program included weekly
educational curriculum, human health coaching, connected tracking tools, and peer support from a virtual
group. Qualitative data on implementation was collected with semi-structured interviews with key informants to
understand the barriers, keys to success, and best practices in the adoption of the program within the clinical
setting.
This paper describes the study design and methodology of a digital diabetes prevention program and early
lessons learned related to recruitment, enrollment, and data collection.
1. Introduction
The landmark Diabetes Prevention Program (DPP) trial demon-
strated that lifestyle modification to promote healthful dietary intake,
increased physical activity, and sustained weight loss is successful and
more effective than prescription medication to prevent or delay the
onset of Type 2 diabetes [1,2]. The success of the DPP lifestyle inter-
vention in the original trial and the long-term salutary benefits found in
the DPP Outcomes Study (DPP-OS) have firmly established the role of
behavioral intervention as effective, safe, and sustainable for diabetes
prevention [3]. With the preponderance of evidence supporting the
DPP, policy efforts are successfully improving provider infrastructure
and expanding health insurance coverage to make diabetes prevention
more accessible to at-risk populations [4,5]. Translational efforts have
disseminated the DPP through various modes of delivery, including in-
person groups and online/digital formats. On average, these transla-
tional DPP efforts have achieved positive results in replicating the goals
of the DPP, and have expanded the reach of lifestyle modification na-
tionwide [6,7]. In particular, technology-enabled and digital versions of
the DPP (utilizing remote coach access, internet platforms,
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telecommunications and smartphone apps) have achieved positive
clinical efficacy, with several meta-analyses showing clinically mean-
ingful weight-loss in the range of 3–4 kg [8], and digital programs
performing comparable to or better than in-person programs in
achieving meaningful weight loss and glycemic control [9,10].
While diabetes prevention efforts continue to proliferate, the in-
cidence of Type 2 diabetes and obesity remain disproportionately
higher among Americans from lower income brackets, particularly low-
income Americans from underrepresented racial and ethnic groups
[11,12]. As with all components of health care, concerted efforts are
needed to ensure low-income individuals have equitable access to
diabetes prevention programs. In fact, many DPP adaptations targeting
low-income communities to better address socioeconomic challenges
have been developed and tested, with modest but promising results
[13–17]. Persistent limitations to many of the DPP adaptations is the
dependency on face-to-face contact, location-based meetings, and time-
restricted options for group sessions. Limited flexibility around work
schedules, access to reliable transportation, or access to affordable
childcare options are reported to pose challenges for potential partici-
pants to attend the required in-person DPP sessions [18,19]. People in
rural areas face similar access obstacles when locations for DPP group
sessions may be logistically prohibitive [20].
To address these logistical and scheduling barriers, remotely deliv-
ered DPP solutions using telecommunications and internet delivery
present a viable option for hard-to-reach populations. While lower-in-
come Americans continue to lag behind higher income groups in
technology adoption and use of technology for health care [21], now
over 60% of low-income Americans own a smartphone, and over half
own a laptop and have broadband internet access at home [22]. Fur-
thermore, a recent study found that 71% of surveyed low-income pa-
tients receiving care through medical safety net services (i.e., sub-
sidized medical care for income limited, uninsured and underinsured
individuals) were interested in using digital tools for health care com-
munication [23]. Technology-enabled DPPs are now emerging to serve
vulnerable populations with evidence of good engagement levels, im-
proved knowledge, and increased behavioral intentions [24,25].
The purpose of this study is to evaluate a digitally-delivered version
of the DPP that was specially adapted for lower-income populations.
This evaluation collects both quantitative and qualitative data on the
experience of patients utilizing the digital DPP to evaluate clinical
outcomes and to better understand the clinic implementation of the
program in facilities serving low-income populations. This paper out-
lines the methods used in conducting the trial and shows the results of
preliminary baseline data analysis.
2. Methods
2.1. Study design
The trial is a non-randomized, controlled trial with historical,
matched controls serving as the comparison group. A non-randomized
design was chosen because sufficient resources were not available for a
randomized clinical trial, and because there were no alternative pro-
grams available for the targeted population with prediabetes.
Investigators were concerned that sites and participating clinicians
would be less receptive to refer patients to the study if there was a
control arm since some of their patients might not receive any services.
An ethical and practical alternative with the resources available was to
offer the program to all eligible patients that were identified, and utilize
a historical comparison group.
A total of 230 participants were recruited over a 14-month period
from three health care facilities serving Medicaid-insured, safety net
insured, or uninsured individuals. The three facilities include a feder-
ally qualified health center located in Southern California, an out-
patient clinic located within a large public teaching hospital in
Southern California, and a clinic serving large numbers of Medicaid
patients operating within a large, not-for-profit, integrated healthcare
network in the state of Washington. All qualified participants enrolled
in the trial were offered the digital DPP program. A comparison group
was created using the same criteria used to determine study eligibility
and was abstracted from de-identified records of patients who did not
enroll in the trial. The study protocol was reviewed and approved by
Western Institutional Review Board and the Health Sciences
Institutional Review Board at University of Southern California.
2.2. Recruitment and eligibility criteria
Participants were initially identified through their electronic health
record (EHR) or through referral from their primary care physician.
Study coordinators made contact on behalf of the study through secure
email, secure text messaging, or in-person meetings in the clinics.
Coordinators had private conversations with all identified/referred
participants to elicit their interest in participation and ensure that the
following eligibility criteria were met: evidence of prediabetes defined
by either a fasting blood glucose test of 100–125mg/dL, glycosylated
hemoglobin (HbA1c) test of 5.7–6.4%, or an oral glucose tolerance test
result of 140–199mg/dL performed within 6 months of the EHR review
date; age 18–75 years at time of screening; insured through Medicaid, a
federally subsidized Affordable Care Act marketplace plan, or unin-
sured; able to speak and read English or Spanish at a 5th grade level or
higher; body mass index (BMI) greater than or equal to 24 kg/m2; able
to access and use the internet at least once a week; and able and willing
to give informed consent to participate. Potential participants were
excluded if they had any of the following: diagnosis of Type 1 or 2
Diabetes; taking insulin, metformin, or other hypoglycemic agent;
pregnant or planning to become pregnant during the trial period; cur-
rently active/acute medical or psychiatric condition that would pre-
clude program participation (i.e., under treatment for acute myocardial
infarction, unstable hypertension); any physical limitation that would
preclude unsupervised exercise (e.g., severe bone or joint pain); current
or suspected drug or alcohol misuse; or instability in living situation
that would preclude full participation.
2.3. Intervention
All enrolled participants received a language-and-literacy adapted
version of the Omada Health Program. The Omada Health Program is a
digital intensive lifestyle intervention that includes virtual group sup-
port, personalized health coaching, weekly lessons, and digital tracking
tools. The program is a Diabetes Prevention Program (DPP) and is re-
cognized by the Diabetes Prevention Recognition Program (DPRP) [4].
The program is 12 months long, with an initial intensive 16-week phase
(considered the “Core” program by DPRP standards) followed by a 36-
week maintenance phase. Participants are placed into small virtual
groups with peers. They start the program at the same time, and are
assigned to the same, live health coach. Each group has a private online
social network where they can discuss goals, challenges, progress, and
provide social support to one another at any time, similar to a private
chat board or discussion board. Users asynchronously complete weekly
health education lessons each week. The lessons are available on the
digital platform and can be accessed through internet or smartphone.
User communicate with their health coach and receive individualized
counseling through private messaging on the platform; coaches also
facilitate discussions on the group chat board. Users track meals using
digital online tracking tools, track weight loss and physical activity
using a wireless weight scale and pedometer, and monitor their en-
gagement and weight loss progress. See Figs. 1 and 2 for visual ex-
amples of the program.
The linguistically adapted version includes all components of the
standard digital DPP but has enhanced features for lower-literacy ac-
cessibility. In previous iterative development work, the following
adaptations were made: 1) revision of the curriculum text and reading
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content to a 4th-5th grade reading level; 2) cultural adaptions of the
curriculum, health coach messaging, recipes and meal plans to be more
economically, culturally, and environmentally sensitive, based on
feedback from a series of focus groups; and 3) Spanish translation of the
curriculum. These adaptations were pilot tested in a sample of 40
participants, and the program was found to be feasible and acceptable
to the target audience [26]. Two of the three clinical sites offered the
Spanish and English versions of the program, and one site offered only
English.
After study eligibility and study enrollment activities were com-
pleted, site study coordinators assisted participants in finding the
Program enrollment homepage and setting up a user account. Once that
step was completed, the program conducted all outreach by email to
participants to notify them of their program start date, introduced them
to their coach with a link to an online video welcome, and sent emails
or app push notifications (when enabled) to alert them when lessons
were open for access, or when group/coach communications were
posted. Participants could access the program at any time on any in-
ternet-enabled device.
2.4. Matched comparison group
A comparison group of patients with similar demographics were
selected from each site to be used as historical controls in a matched
control design [27]. EHR records were abstracted for patients meeting
the following inclusion criteria: (1) prediabetes as defined by fasting
blood glucose of 100–125mg/dL or HbA1c 5.7–6.4% within the past 12
months, (2) age 18 and older, (3) insured by Medicaid, safety net in-
surance, or uninsured, (4) speaks/reads English or Spanish, (5) BMI of
24 or greater; and the following exclusion criteria (1) evidence of a
diagnosis of Type 1 or Type 2 Diabetes, (2) evidence of prescription for
insulin, metformin or any other hypoglycemic agent, and (3) evidence
of current pregnancy. The comparison group was comprised of patients
who were matched to age, gender race/ethnicity, and baseline BMI as
closely as possible to the participants receiving the intervention. All
records of BMI and blood glucose test results were abstracted for a 12
month period, where available. Sites were allowed to search for the
matched control cases within 12 months prior to the start of enrollment
or concurrent with enrollment period of the trial. This approach al-
lowed a maximum 24-month window to find a matched comparison
group.
2.5. Measurements
After eligibility was confirmed and participants provided informed
consent in their preferred language, participants completed a set of
clinical and psychosocial measurements with the study coordinator.
These measures were only collected on participants receiving the in-
tervention; matched comparator subjects did not complete these mea-
surements.
Body Composition. Height and weight were collected by the study
coordinators using calibrated stadiometers and weight scales in the
Fig. 1. Sample home page of the Omada Health Program.
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health care clinics; from these data, body mass index is calculated from
weight in kilograms divided by height in meters squared (kg/m2).
Additionally, once enrolled in the DPP, participants were mailed a
wireless weight scale (BodyTrace, Inc., New York, NY) that was linked
to their online program account. Participants were encouraged to weigh
themselves every day at the same time of day, preferably in the morning
before eating or dressing. The scale automatically and securely trans-
mitted weights to the program database using the cellular GSM net-
work. The participant's program starting weight is captured before they
began receiving any educational or support content from the program.
Blood Glucose. Glycosylated hemoglobin (HbA1c) was measured in
percentage (NGSP/DCCT) units using self-administered AccuBase A1c
test kits (DTI laboratories, Thomasville, GA). The kit includes an FDA-
cleared, whole blood fingerstick test that uses a capillary tube blood
collection method. Study site coordinators dispensed an A1c kit to
participants at the baseline, 6 month, and 12 month visits. Participants
are not required to fast prior to taking the blood sample for an A1c test,
and can give the sample at any time of day. Participants completed the
fingerstick blood sample collection independently and mailed the pre-
served blood samples to a central processing lab for analysis. A central
coordinator was notified of the results, who relayed the information to
the specific site coordinators.
Blood Pressure and Lipids. One clinical site also collected resting
blood pressure and blood lipids measurements on a subsample of par-
ticipants at all time points. Blood pressure was measured after a brief
resting period, in a seated position with both feet on the floor, using an
automated blood pressure monitor with arm cuff, with the arm elevated
to heart level (Omron, model HEM-712C, Kyoto, Tokyo). Blood lipids
were measured using a non-fasting, whole blood fingerstick with a
capillary tube, processed with the Cholestech LDX Analyzer (Alere Inc.,
Waltham, MA). The analyzer meets National Cholesterol Education
Program (NCEP) performance goals and is certified by the Centers for
Disease Control and Prevention Lipid Standardization Program [28].
Patient-Reported Outcomes. Site study coordinators conducted in-
terviews to collect demographic information at baseline including
marital status, household size, gender identity, race/ethnic identity,
preferred language, educational status, and current employment status.
Measures of psychosocial and environmental factors that may con-
tribute to program efficacy were collected through an interviewer-ad-
ministered survey (conducted by the site coordinator) prior to the start
of the program, and will be re-administered at 6 months and 12 months.
Self-rated health was assessed at baseline and re-assessed at both 6
months and 12 months. The single-item measure prompts readers to
rate their health as excellent, very good, good, fair, or poor, and has
Fig. 2. Sample lesson page.
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been shown to generate an accurate reflection of actual health status
[29].
Language proficiency in English and Spanish was ascertained with 8
items (4 for English language proficiency, 4 for Spanish) that were
taken from U.S. Census and adapted in previous culturally-sensitivity
measurement research [30,31]. The items ask the respondent to rate
their proficiency in speaking, understanding, reading, and writing in
the language of interest. A cutpoint of 3 is recommended to identify
people with limited English proficiency [31].
Health literacy was measured with the single item health literacy
question [32]. This single-item asks “How confident are you filling out
medical forms by yourself?” and users respond on a numeric scale of 1
(extremely) to 5 (not at all), with scores of 3 or higher identifying in-
dividuals with inadequate health literacy. This single item has been
validated against established health literacy assessment measures [32].
Health care utilization was measured with a scale from the Hispanic
Community Health Study/Study of Latinos [33]. Respondents were
asked to identify where they received most of their care, whether they
encountered a time when they needed care but could not get it, reasons
why, and if they could not obtain specific elements of care due to fi-
nancial constraints.
Program Engagement. It was unclear if lower-income people would
be able to easily access a technology-enabled program. Therefore, we
captured program usage features to determine if participants were able
to utilize all components. The web-supported platform was capable of
capturing frequency of user log-ins, number of times they measure
weight on a connected scale, number of curriculum lessons completed,
use of the food and activity tracking logs, and frequency of commu-
nication on the group messaging board and with the health coach. The
National DPP has quality metrics anchored on lesson completion [6],
and thus, we will be able to benchmark this sample to national norms.
Qualitative Interviews. Qualitative data on implementation were
collected with semi-structured interviews with key informants at the
clinics to understand the barriers, keys to success, and best practices in
the adoption of the program within the clinical setting. Study in-
vestigators visited each of the three sites and interviewed key staff in-
cluding the site's program manager, the enrollment coordinator, and
individual providers who referred their patients to the trial. The aim of
the semi-structured interviews was to understand the implementation
process from the staff's perspectives. The interview questions asked
about each site's motivation for participating in the trial, their under-
standing of the trial, expectations, recruitment strategies, and chal-
lenges or obstacles. Some examples of questions asked to probe the staff
were: “How well did you understand the study project during its
planning phase, that is, leading up to recruitment?”, “How did you try
to recruit patients into the program?”, “In your opinion, what was the
most successful strategy for recruiting patients?” and “What were the
obstacles?” The referring clinicians were also asked about their com-
munication with the study staff, any follow-up with their patients re-
garding the trial, and their thoughts on whether the program was
beneficial for their patients.
Finally, five focus groups of enrollees were conducted, one each at
each of the study locations conducted in English and two focus groups
in Spanish. To get a representation of participants across the spectrum
of program engagement, we recruited participants with 5 or fewer DPP
lessons completed, and those with 9 or more lessons completed. The
focus groups queried enrollees about the challenges in participating in
the program and contributors to successful participation. Qualitative
data from focus groups were collected from semi-structured discussion
guides by one facilitator and one note taker. The focus groups were
audio-recorded and translated to English or translated verbatim. Two
reviewers analyzed and coded the transcripts for common and unique
themes. The research team reviewed the themes and identified common
themes if they surfaced in two or more focus groups. When a theme
emerged in only one group, it was identified as a unique theme.
2.6. Sample size calculation
The study was powered to detect a statistically significant, pre-post
difference of 3% weight loss in the treated group relative to a 0%
weight reduction expected in the comparison group. Based on similar
studies with comparable populations [34], we estimated a 4% standard
deviation across groups. With alpha=0.05 and power= 0.8, we esti-
mate a minimal sample size of 40 per group was necessary to detect a
3% difference in weight. At the time the study was conceived (2015),
estimated churn rates for Medicaid varied between 20 and 50%
[35,36], from which we expected a 30–40% loss-to-follow up rate.
Factoring in the potential to analyze subgroups of the sample based on
language and sites, we planned to recruit up to 100 participants at the
two sites with a bilingual population and 40 at the English-only site,
and after adjusting for loss-to-follow-up rate, expect to recruit and re-
tain an analyzable sample size of 200.
3. Results
Study recruitment, screening, and enrollment took place at the three
sites between February 2016 and March 2017. Across all sites, and
through referrals from clinicians and regular reviews of available in-
formation in the EHR (primarily BMI, any lab test results for blood
glucose, and age), a total of 273 participants were identified as po-
tentially eligible from the EHR and were approached and screened; of
these, 14 were determined to be ineligible for the following reasons:
five did not meet the BMI criteria; three were pregnant; two were
prescribed metformin for prediabetes, two expressed discomfort
reading and writing; one person lacked reliable internet access; and one
was already in a weight management program. An additional seven
participants declined to continue after the screening interview, stating
they were either too busy to participate or no longer interested. Of the
remaining 253 that were interested and eligible, 23 did not complete
the online registration process for the digital diabetes prevention pro-
gram. Thus, out of the 273 approached, 230 individuals (84%) were
placed in virtual groups assigned a health coach and started the inter-
vention.
Table 1 shows the baseline demographic characteristics of program
participants. Overall, the participants were predominantly women in
their late-forties. Two-thirds of all participants identified with His-
panic/Latino ethnicity and 61% of all participants were born outside
the U.S. Among them, the average number of years living in the U.S was
25.0 (SD=10.2). Forty six percent of participants endorsed Spanish as
their preferred language (71% of Hispanic/Latino participants), and
42% of the sample were identified as having limited English profi-
ciency.
At baseline, the average finger-stick A1c test result was 5.8%
(SD=0.39). Baseline BMI was 34.53 kg/m2 (SD=7.86), with an
average weight of 199.3 pounds (SD=55.4) and median weight of 190
pounds. In the subset of 75 participants who completed blood pressure
and lipids data collection, 38% had elevated blood pressure
(systolic > 129mmHg, diastolic > 85mmHg), 36% had elevated
total cholesterol (> 200mg/dL), 49% had high density lipoproteins
(HDL) in the at-risk range (HDL<50mg/dL), and 55% had triglycer-
ides in the at-risk range (> 150mg/dL). Only 10% of participants re-
ported self-rated health of Very Good or Excellent, 34% reported it as
Good, 45% as Fair, and 11% as Poor.
On the one-item health literacy screener, 27% of the sampled rated
themselves a three or higher, indicating inadequate health literacy.
However, 23% rated themselves a two or “quite a bit” comfortable, and
49% rated themselves as “extremely” comfortable filling out medical
forms on their own. In terms of health care utilization, 99% reporting
receiving their health care in the US in the past year, and only 8.5%
reported a time when they needed care but could not get it. The top
reasons were (1) they couldn't get an appointment for care soon en-
ough, and (2) they could not afford it. When asked about other elements
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of health care, 28% reported not getting dental care in the past year
because they could not afford it, 27% reported not getting prescription
glasses due to the cost, and 13% reported not getting prescription
medications due to cost.
Table 2 shows participants' use of different technology devices and
comfort with computers. The majority of the sample (60%) used a
computer at least once a week. Similarly, overall comfort with using
computers was high (61% reported feeling very comfortable).
A preliminary analysis of the qualitative interviews with key staff
and referring clinicians showed that there was enthusiasm for im-
plementing a digital diabetes prevention program because there was
lack of available programs for their patient population. From the qua-
litative interviews, the clinicians stated they welcomed the opportunity
to refer patients to the program. However, we found that only a few
were responsible for consistently referring patients. In each of the sites,
one or two clinicians referred most of the patients to the program. All
referring clinicians who were interviewed indicated that it would have
been helpful to receive updates about the progress of their patients in
the program. The clinicians were not informed and were unaware of
which of their patients enrolled in the trial. Because of the lack of
communication between the study staff and referring clinicians, some
clinicians may have lost incentive to refer their patients to participate
after the initial introduction. Many patients expressed to the study co-
ordinators that they were excited to participate because of the oppor-
tunity to better manage their health and receive assistance in adopting
lifestyle changes to reduce their risk of progressing to type 2 diabetes.
The participants also mentioned to coordinators their appreciation for
the flexibility of the online format and the benefit of fitting the inter-
vention into their schedule.
4. Discussion
Previous studies have shown that lifestyle modification is a suc-
cessful approach to preventing diabetes and reducing the risk of de-
veloping diabetes. We found that it is feasible to recruit a safety net
population unfamiliar with online or digital health programs to parti-
cipate in a digitally-delivered diabetes prevention program. When ap-
proached, a majority of the patients had access to a computer or a
mobile handheld device and were receptive to an online/digital pro-
gram. We were able to recruit a large and diverse sample of low-income
participants who could benefit from a DPP. Very few participants
(n= 9) were ineligible due to lack of prediabetes or overweight/obese
status; this indicates that EHR data and clinician accuracy for identi-
fying clinically eligible patients for a DPP was reliable.
Our initial assessment of the trial also showed that there were
various challenges and barriers at different phases of the intervention
related to referrals, enrollment, and data collection.
Referrals. The program managers at each of the three participating
health care facilities were responsible for identifying the appropriate
clinics and introducing the study to the clinicians and patients.
Clinicians at each of the sites were informed of the study and asked to
refer their patients to the clinical trial. Introductory study presentations
and the sending of reminders to clinicians had a limited effect on in-
creasing referrals. Some clinicians indicated that frequent and regular
communication from the study staff about patients' progress in the
program would have motivated more referrals. To meet the targeted
enrollment numbers, other recruitment strategies had to be im-
plemented, primarily direct patient outreach to patients identified
through the EHR. We found that it was important to tailor recruitment
strategies to the targeted population and continue to communicate with
the site staff to modify strategies. For example, recruitment by handing
out information pamphlets at health fairs or talking to patients in clinic
waiting rooms was often effective. Dedicated staff at each recruitment
site (employed at least half-time on the study) who approached po-
tentially eligible participants by phone or in person at a clinic were
responsible for most of the enrollments. In the focus groups, partici-
pants mentioned that they were more receptive to being approached by
the coordinator to participate in the trial because their doctor had
previously discussed it with them.
Enrollment. There were also challenges in completing the require-
ments for enrollment. Although enrolled subjects rated their comfort
with computers on the high end in the self-report assessment, many of
the participants demonstrated limited proficiency in using computers or
mobile devices when it was time to enroll in the digital program. This
discrepancy suggests that some participants were comfortable using
Table 1
Baseline characteristics.
Demographic Participants (n= 230)
Female, n (%) 186 (81%)
Average age in years, (SD) 48 years (12)
Racial Identity, n (%)
White (Hispanic or non-Hispanic) 156 (68%)
Black or African-American 16 (7%)
Asian 11 (5%)
More than one race 11 (5%)
Prefer not to answer 36 (16%)
Ethnicity, n (%)
Hispanic or Latino 151 (66%)
Not Hispanic or Latino 69 (30%)
Prefer not to answer 10 (4%)
Preferred Language, n (%)
English 122 (53%)
Spanish 106 (46%)
Health Insurance, n (%)
Medicaid or MediCal 181 (79%)
Uninsured 44 (19%)
Safety net program 5 (2%)
Education, n (%)
Less than 8th grade 46 (20%)
Some high school 41 (18%)
High school diploma or GED 46 (20%)
Some college 60 (26%)
2-year college degree 11 (5%)
4-year college degree 17 (7%)
Some graduate level education 6 (3%)
Prefer not to answer 3 (1%)
Employment status
Homemaker/Not employed for wages 75 (33%)
Work part-time (< 40 h) 52 (23%)
Work full-time (≥40 h) 66 (29%)
Retired 10 (4%)
Unable to work/Disabled 21 (9%)
Prefer not to answer 6 (3%)
Table 2
Baseline technology use among program participants.
Variable Participants (n= 230)
Own mobile phone, n (%)
Yes 180 (78%)
No 4 (2%)
Refused 46 (20%)
Use wearable device, n (%)
Yes 16 (7%)
No 162 (70%)
Refused 52 (23%)
Frequency of computer use, n (%)
Every day 70 (33%)
Almost every day 37 (17%)
About once a week 22 (10%)
Once every few weeks 19 (9%)
Rarely or never 63 (30%)
Comfort with computers, n (%)
Very uncomfortable 23 (11%)
Somewhat uncomfortable 30 (14%)
Very comfortable 130 (61%)
I have never used them 27 (13%)
Refused 2 (1%)
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certain familiar features of their phones and computers, but when
challenged with a new process (e.g., finding and downloading a specific
app, or navigating a sign-up form webpage), others may have been less
comfortable and less likely to engage in the digital tools. The enroll-
ment coordinators spent time with enrolled subjects to provide tech-
nical support. Some participants needed help in completing the online
enrollment and baseline surveys, as well as initially completing the
application and account creation for the digital program. In particular,
Spanish-speakers needed extra help with the initial sign-up process to
access the program. It took more time and effort than planned to ensure
that the participants completed all the enrollment requirements.
However, data elements from the digital program's internet connected
devices are still transmitting and collecting data (i.e., the weight scale,
the nutrition and activity trackers), so we will have data to demonstrate
participants' program engagement and outcomes even if they do not
respond to the study coordinators attempts to schedule follow-up visits.
At the time the study was launched, some elements of the online
program were not hard coded in both Spanish and English, and required
adjusting web browser or operating system (OS) language settings to
Spanish on laptops, tablets or smartphones. These browser/OS trans-
lations were not as robust, and led to some confusion because of im-
precise translations or instructions that were misunderstood upon
translation. The digital health company has since invested resources to
improve and enhance these elements for a better user experience.
Data Collection. Information was collected from both the partici-
pants and the health care facilities. Participant data were collected at
baseline, 6-months, and 12-months. Some patients were uncomfortable
with the self-administered fingerstick HbA1c home-kit that was re-
quired at study enrollment. Many patients wanted to complete the
baseline HbA1c in the clinic, and the rate of completing the test at home
was lower than expected and required reminders and occasional repeat
tests to get an adequate sample. Although we have complete baseline
data, contacting participants to schedule follow-up visits has been more
challenging than expected. Many calls were unanswered and staff have
to make multiple attempts to get a response.
Second, there were also barriers to obtaining historical health re-
cord data from the three participating health care facilities. We have
been working with the project managers at each of the sites to identify
the matched sample for comparison and extract their data on health
care utilization. These data were difficult to isolate and extract, and the
lack of human resources at those facilities to extract the data proved
challenging. We are learning that patient data is often incomplete and
the quality of the comparison data may not be optimal, in part due to
the electronic health records that were not designed to extract data for
research purposes.
In this trial, although there were some challenges, we successfully
recruited, enrolled, and engaged a low-income population at risk for
developing diabetes to participate in a digital diabetes prevention
program. The results of this trial will contribute meaningfully to the
field of mobile health interventions in underserved populations.
Information gathered from the study participants in focus groups will
provide valuable insights into the usefulness of the program adapta-
tions, how the program fit into their lives, and any barriers to success
that were encountered throughout the study period. The initial results
demonstrating interest and receptivity to the program are encouraging,
and work towards dispelling the myth that underserved populations are
unwilling and/or unable to successfully engage with health technology.
The changes in weight and HbA1c at 6 months and 12 months will
provide insight into how well digital diabetes prevention programs
work to help underserved populations make lifestyle modifications to
reduce risk for diabetes. Additionally, the lessons learned during the
implementation of the trial regarding recruitment, enrollment, and data
collection should inform future integrations of diabetes prevention
program implementation and delivery in health care systems serving
lower-income populations.
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